[Combined surgical and specific passive xenogenic immunotherapy in UVT tumor-bearing inbred XVII/Bln mice].
The influence of surgical tumor exstirpation and application of 9,6 x 10(6) sensitized rabbit lymphocytes in inbreeding mice was compared with unique surgical therapy. No therapeutic result existed with unique immunotherapy and advanced growth of the tumor (Winzer and Wolf). 74% of the mice were alive with combined therapy on the 21st day after operation respectively on the 31st day after transplantation. On the other hand only 53% of the mice were alive with surgical therapy alone. A clinical use of a unique passive xenogenous immunotherapy does not appear to be indicated, because there was not reached a constant remission.
D000818:Animals; D003602:Cytotoxicity, Immunologic; D007116:Immunization, Passive; D017710:Lymphocyte Transfusion; D008214:Lymphocytes / Q000276:immunology; D051379:Mice; D008815:Mice, Inbred Strains; D009368:Neoplasm Transplantation; D009374:Neoplasms, Experimental / Q000276:immunology / Q000601:surgery*; D011817:Rabbits; D014183:Transplantation, Heterologous
Kombinierte chirurgische und spezifische passive xenogene Immuntherapie bei UVT-Tumor tragenden Inzuchtmäusen XVII/Bln.